The osteoporosis care gap in Canada
<p>Abstract</p> <p>Background</p> <p>The presence of a fragility fracture is a major risk factor for osteoporosis, and should be an indicator for osteoporosis diagnosis and therapy. However, the extent to which patients who fracture are assessed and treated for osteopor...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2004-04-01
|
| Series: | BMC Musculoskeletal Disorders |
| Subjects: | |
| Online Access: | http://www.biomedcentral.com/1471-2474/5/11 |
| _version_ | 1811329376042614784 |
|---|---|
| author | Boulos P Kvern B Giangregorio L Papaioannou A Ioannidis G Adachi JD |
| author_facet | Boulos P Kvern B Giangregorio L Papaioannou A Ioannidis G Adachi JD |
| author_sort | Boulos P |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p>The presence of a fragility fracture is a major risk factor for osteoporosis, and should be an indicator for osteoporosis diagnosis and therapy. However, the extent to which patients who fracture are assessed and treated for osteoporosis is not clear.</p> <p>Methods</p> <p>We performed a review of the literature to identify the practice patterns in the diagnosis and treatment of osteoporosis in adults over the age of 40 who experience a fragility fracture in Canada. Searches were performed in MEDLINE (1966 to January 2, 2003) and CINAHL (1982 to February 1, 2003) databases.</p> <p>Results</p> <p>There is evidence of a care gap between the occurrence of a fragility fracture and the diagnosis and treatment of osteoporosis in Canada. The proportion of individuals with a fragility fracture who received an osteoporosis diagnostic test or physician diagnosis ranged from 1.7% to 50%. Therapies such as hormone replacement therapy, bisphosphonates or calcitonin were being prescribed to 5.2% to 37.5% of patients. Calcium and vitamin D supplement intake was variable, and ranged between 2.8% to 61.6% of patients.</p> <p>Conclusion</p> <p>Many Canadians who experience fragility fracture are not receiving osteoporosis management for the prevention of future fractures.</p> |
| first_indexed | 2024-04-13T15:42:47Z |
| format | Article |
| id | doaj.art-185dbfd89ebd43ff8f332b9df6f1ccba |
| institution | Directory Open Access Journal |
| issn | 1471-2474 |
| language | English |
| last_indexed | 2024-04-13T15:42:47Z |
| publishDate | 2004-04-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Musculoskeletal Disorders |
| spelling | doaj.art-185dbfd89ebd43ff8f332b9df6f1ccba2022-12-22T02:41:05ZengBMCBMC Musculoskeletal Disorders1471-24742004-04-01511110.1186/1471-2474-5-11The osteoporosis care gap in CanadaBoulos PKvern BGiangregorio LPapaioannou AIoannidis GAdachi JD<p>Abstract</p> <p>Background</p> <p>The presence of a fragility fracture is a major risk factor for osteoporosis, and should be an indicator for osteoporosis diagnosis and therapy. However, the extent to which patients who fracture are assessed and treated for osteoporosis is not clear.</p> <p>Methods</p> <p>We performed a review of the literature to identify the practice patterns in the diagnosis and treatment of osteoporosis in adults over the age of 40 who experience a fragility fracture in Canada. Searches were performed in MEDLINE (1966 to January 2, 2003) and CINAHL (1982 to February 1, 2003) databases.</p> <p>Results</p> <p>There is evidence of a care gap between the occurrence of a fragility fracture and the diagnosis and treatment of osteoporosis in Canada. The proportion of individuals with a fragility fracture who received an osteoporosis diagnostic test or physician diagnosis ranged from 1.7% to 50%. Therapies such as hormone replacement therapy, bisphosphonates or calcitonin were being prescribed to 5.2% to 37.5% of patients. Calcium and vitamin D supplement intake was variable, and ranged between 2.8% to 61.6% of patients.</p> <p>Conclusion</p> <p>Many Canadians who experience fragility fracture are not receiving osteoporosis management for the prevention of future fractures.</p>http://www.biomedcentral.com/1471-2474/5/11osteoporosisfractureCanadadiagnosistreatment |
| spellingShingle | Boulos P Kvern B Giangregorio L Papaioannou A Ioannidis G Adachi JD The osteoporosis care gap in Canada BMC Musculoskeletal Disorders osteoporosis fracture Canada diagnosis treatment |
| title | The osteoporosis care gap in Canada |
| title_full | The osteoporosis care gap in Canada |
| title_fullStr | The osteoporosis care gap in Canada |
| title_full_unstemmed | The osteoporosis care gap in Canada |
| title_short | The osteoporosis care gap in Canada |
| title_sort | osteoporosis care gap in canada |
| topic | osteoporosis fracture Canada diagnosis treatment |
| url | http://www.biomedcentral.com/1471-2474/5/11 |
| work_keys_str_mv | AT boulosp theosteoporosiscaregapincanada AT kvernb theosteoporosiscaregapincanada AT giangregoriol theosteoporosiscaregapincanada AT papaioannoua theosteoporosiscaregapincanada AT ioannidisg theosteoporosiscaregapincanada AT adachijd theosteoporosiscaregapincanada AT boulosp osteoporosiscaregapincanada AT kvernb osteoporosiscaregapincanada AT giangregoriol osteoporosiscaregapincanada AT papaioannoua osteoporosiscaregapincanada AT ioannidisg osteoporosiscaregapincanada AT adachijd osteoporosiscaregapincanada |